Ivan Bièche
Impact in
- Cancer Research top 0.1%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Cancer-related molecular mechanisms research
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers
Papers in
- Cancer Research 152
- Breast Cancer Treatment Studies 92
- Cancer Genomics and Diagnostics 43
- Oncology 102
- HER2/EGFR in Cancer Research 25
- Co-authors
- Rosette Lidereau (141 shared papers)Michel Vidaud (89 shared papers)Ingrid Laurendeau (62 shared papers)Sophie Vacher (129 shared papers)Dominique Vidaud (30 shared papers)Sengül Tozlu (20 shared papers)Éric Pasmant (18 shared papers)Martine Olivi (14 shared papers)
- Journals
- British Journal of Cancer (27 papers)Annals of Oncology (21 papers)Oncogene (19 papers)International Journal of Cancer (18 papers)Clinical Cancer Research (17 papers)
- Partner nations
- FranceUnited StatesUnited Kingdom
In The Last Decade
Ivan Bièche
562 papers receiving 28.2k citations
Ivan Bièche's Hit Papers
Peers
Comparison fields: 5 of 150
- Cancer Research 6.9k
- Oncology 4.7k
- Hepatology 1.4k
- Genetics 922
- Genetics 3k
Countries citing papers authored by Ivan Bièche
This map shows the geographic impact of Ivan Bièche's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivan Bièche with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivan Bièche more than expected).
Fields of papers citing papers by Ivan Bièche
This network shows the impact of papers produced by Ivan Bièche. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivan Bièche. The network helps show where Ivan Bièche may publish in the future.
Co-authors
The 25 scholars most cited alongside Ivan Bièche, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 570 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial Hit paper breakdown → | 2015 | 899 |
| 2 | Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group Hit paper breakdown → | 2020 | 890 |
| 3 | 2007 | 533 | |
| 4 | 2006 | 469 | |
| 5 | 2010 | 384 | |
| 6 | Expression analysis of DNA methyltransferases 1, 3A, and 3B in sporadic breast carcinomas. | 2003 | 297 |
| 7 | 2007 | 295 | |
| 8 | 1995 | 268 | |
| 9 | 2013 | 267 | |
| 10 | Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised, open-label, multicentre, phase 3 trial Hit paper breakdown → | 2022 | 255 |
| 11 | 2014 | 247 | |
| 12 | 2017 | 243 | |
| 13 | 2014 | 238 | |
| 14 | 2020 | 238 | |
| 15 | Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group Hit paper breakdown → | 2024 | 231 |
| 16 | 1999 | 226 | |
| 17 | 2011 | 226 | |
| 18 | Quantitation of MYC gene expression in sporadic breast tumors with a real-time reverse transcription-PCR assay. | 1999 | 221 |
| 19 | Evaluation of androgen, estrogen (ER alpha and ER beta), and progesterone receptor expression in human prostate cancer by real-time quantitative reverse transcription-polymerase chain reaction assays. | 2001 | 215 |
| 20 | 2004 | 208 |
About Ivan Bièche
Ivan Bièche is a scholar working on Cancer Research, Oncology, Genetics, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 570 papers that have together received 28.8k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (92 papers), Cancer Genomics and Diagnostics (43 papers), BRCA gene mutations in cancer (42 papers), Breast Lesions and Carcinomas (38 papers), Angiogenesis and VEGF in Cancer (27 papers), HER2/EGFR in Cancer Research (25 papers), Lung Cancer Treatments and Mutations (24 papers) and Estrogen and related hormone effects (24 papers). The work is most often cited by research in Cancer Research (6.9k citations), Oncology (4.7k citations), Hepatology (1.4k citations), Genetics (922 citations) and Genetics (3k citations). Ivan Bièche has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Rosette Lidereau, Michel Vidaud, Ingrid Laurendeau, Sophie Vacher, Dominique Vidaud, Sengül Tozlu, Éric Pasmant, Martine Olivi, M.H. Champème and Tarik Asselah. Their work appears in journals such as British Journal of Cancer, Annals of Oncology, Oncogene, International Journal of Cancer and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.